Company urged Florida not to use its drug in execution 'cocktail'

For years, Illinois-based Hospira Inc. worried about its drugs being used across the country for lethal injections. So, a company spokesman says, Hospira sent letters to all the states annually — including Florida — stating its opposition to the drugs' use to carry out death sentences.

But the states, including Florida, continued using at least one Hospira product in the three-drug "cocktail" approved for executions.

There was nothing illegal about that, but their continued use of Hospira products to execute inmates ultimately compelled the company last month to announce its decision to stop all production of its trademarked anesthetic, Pentothal. The supplies that states already have on hand are set to expire this year.

"Hospira provides these products because they improve or save lives and markets them solely for use as indicated on the product labeling," wrote Kees Gioenhout, Hospira's vice president of Clinical Research and Development, in a letter sent to Ohio in March. "As such, we do not support the use of any of our products in capital punishment procedures."

The Florida Department of Corrections has no record of any such letters sent to its headquarters in Tallahassee.

"I have not been able to find the letter or anyone who remembers getting the letter," said corrections spokeswoman Gretl Plessinger. In an earlier e-mail, Plessinger wrote, "I can't find that letter. They didn't send it to the Secretary or legal or Institutions."

But Hospira spokesman Daniel Rosenberg said, "We sent letters to all the states. It was sent to Florida."

Hospira sent letters each year during the past decade, Rosenberg said, sharing concerns about the use of Hospira drugs in executions. Hospira was the sole manufacturer of sodium thiopental, or Pentothal, which was specifically listed in Florida's lethal-injection procedures spelled out by the Department of Corrections secretary in an April 2008 document.

In announcing its decision to cease making the drug, Hospira said it could not ensure that third-party suppliers would never sell the drug to state departments of corrections for use in executions. Authorities in Italy, where the drug was made, were also concerned about — and opposed to — the drug's use in executions in the United States.

Source: Orlando Sentinel, Feb. 22, 2011

_________________________

Use the tags below or the search engine at the top of this page to find updates, older or related articles on this Website.